Atu027: Phase Ib/IIa final data

Final data from the Phase IIa portion of the open-label, German Phase Ib/IIa Atu027-I-02 trial in 23 patients

Read the full 180 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE